Subscribe Now for Delta3 AI Alerts
Don’t miss out on top stock picks and market insights. Subscribe to Delta3 AI Alerts for real-time updates and expert analysis straight to your inbox. Stay informed and maximize your investment potential.
Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
- Symbol BCTXL
- Company BriaCell Therapeutics Corp.
- Price $0.8
- Changes Percentage -2.44
- Change -0.02
- Day Low $0.8
- Day High $1
- Year High $1.15
- Year Low $0.88
- Market Cap $9,917,761
- Price Avg 50 EMA (D) $1.02
- Price Avg 200 EMA (D) $1.02
- Exchange NASDAQ
- Volume 8,324
- Average Volume 10,408
- Open $0.84
- Previous Close $0.82
- EPS -12.41
- PE -0.09
- Earnings Announcement 1970-01-01 00:00:00
- Shares Outstanding $8,699,790
Company brief: BRIACELL THERAPEUTICS CORP. (BCTXL )
- Healthcare
- Biotechnology
- William V. Williams
- https://briacell.com
- CA
- N/A
- 01-14-2026
- CA1079301257
BriaCell Therapeutics Corp. is a clinical-stage biotechnology company, which engages in the development of novel immunotherapies to transform cancer care. It currently advancing its Bria-IMT™ targeted immunotherapy in combination with an immune check point inhibitor in a pivotal 1 Phase 3 study in metastatic breast cancer. The company was founded by Charles L. Wiseman and Isaac Benjamin Maresky on July 26, 2006 and is headquartered in West Vancouver, Canada.
